FFO
JAZZ icon

Fortitude Family Office’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fortitude Family Office’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.8K Buy
128
+68
+113% +$14.9K 0.01% 399
2026
Q1 		$11.3K Buy
60
+27
+82% +$4.72K ﹤0.01% 605
2025
Q4 		$5.61K Buy
33
+2
+6% +$307 ﹤0.01% 772
2025
Q3 		$4.09K Hold
31
– – ﹤0.01% 880
2025
Q2 		$3.29K Sell
31
-6
-16% -$652 ﹤0.01% 969
2025
Q1 		$4.59K Sell
37
-6
-14% -$783 ﹤0.01% 754
2024
Q4 		$5.29K Buy
43
+37
+617% +$4.36K ﹤0.01% 825
2024
Q3 		$668 Buy
+6
New +$657 ﹤0.01% 1140

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Fortitude Family Office's JAZZ Position: Q2 2026 in Review

Fortitude Family Office increased its Jazz Pharmaceuticals (JAZZ) stake by 113% in Q2 2026, buying an estimated $14.9K and bringing the position to 128 shares worth $30.8K. The position accounts for 0.01% of the portfolio, ranked #399.

Fortitude Family Office first reported a position in JAZZ in Q3 2024 and has held it in 8 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Fortitude Family Office held 128 shares of Jazz Pharmaceuticals worth $30.8K as of Q2 2026.
  • Fortitude Family Office bought 68 Jazz Pharmaceuticals shares in Q2 2026, an estimated $14.9K.
  • Jazz Pharmaceuticals made up 0.01% of Fortitude Family Office's portfolio in Q2 2026, its #399 holding.
  • Fortitude Family Office first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.